Literature DB >> 8338684

Structural alterations of airway epithelial tight junctions in cystic fibrosis: comparison of transplant and postmortem tissue.

R W Godfrey1, N J Severs, P K Jeffery.   

Abstract

Previous descriptive freeze-fracture studies have suggested that the airway epithelium in cystic fibrosis (CF) is associated with proliferation and basal extension of tight junctional elements. The significance of these reports in CF has been difficult to evaluate because tight junctions are labile structures, capable of alteration, postmortem. The aim of the present study was to test the hypothesis that the abnormalities in tight junction structure reported previously are unique to CF airways, and to determine the confounding effects of postmortem autolysis. To this end, we analyzed human airway epithelial tight junctions in: (1) histologically normal tissue taken from lungs resected for pulmonary tumor (i.e., resection controls), (2) lungs from patients who died of nonrespiratory causes (i.e., postmortem controls), (3) lungs removed from CF patients undergoing transplantation, and (4) lungs from CF patients postmortem. Tight-junctional depth, strand number, and junctional complexity were analyzed. Basal extensions and isolated foci of tight-junctional elements were found in all groups except for the resection controls. The following two parameters were therefore assessed: (1) the number of times a junction extended below the maximal depth found in the resection controls and (2) the extent of junctional elements that were isolated and distant from the apico-lateral junctional belt. The mean frequencies of occurrence of junctional extension beyond the normal maximum were 4.8% for the CF transplant, 23.6% for the control postmortem, and 48.8% for the CF postmortem group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8338684     DOI: 10.1165/ajrcmb/9.2.148

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

Review 1.  Molecular aspects of tight junction barrier function.

Authors:  Guo Hua Liang; Christopher R Weber
Journal:  Curr Opin Pharmacol       Date:  2014-08-14       Impact factor: 5.547

Review 2.  Breaking barriers. New insights into airway epithelial barrier function in health and disease.

Authors:  Fariba Rezaee; Steve N Georas
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

Review 3.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

4.  Measurement of Airway Epithelial Permeability: Methods and Protocols.

Authors:  Hasan Yüksel; Merve Öcalan
Journal:  Methods Mol Biol       Date:  2021

5.  Vitamin D supplementation of initially vitamin D-deficient mice diminishes lung inflammation with limited effects on pulmonary epithelial integrity.

Authors:  Shelley Gorman; Alysia G Buckley; Kak-Ming Ling; Luke J Berry; Vanessa S Fear; Stephen M Stick; Alexander N Larcombe; Anthony Kicic; Prue H Hart
Journal:  Physiol Rep       Date:  2017-08

Review 6.  Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.

Authors:  Virginia De Rose; Kevin Molloy; Sophie Gohy; Charles Pilette; Catherine M Greene
Journal:  Mediators Inflamm       Date:  2018-04-08       Impact factor: 4.711

7.  The PDZ motif peptide of ZO-1 attenuates Pseudomonas aeruginosa LPS-induced airway inflammation.

Authors:  Tae Jin Lee; Yung Hyun Choi; Kyoung Seob Song
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

Review 8.  Invited review: human air-liquid-interface organotypic airway tissue models derived from primary tracheobronchial epithelial cells-overview and perspectives.

Authors:  Xuefei Cao; Jayme P Coyle; Rui Xiong; Yiying Wang; Robert H Heflich; Baiping Ren; William M Gwinn; Patrick Hayden; Liying Rojanasakul
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-11-11       Impact factor: 2.723

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.